Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Van Den Berg, Paul M"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Peters, Solange, Stahel, Rolf A., Dafni, Urania, Ponce Aix, Santiago, Massutí, Bartomeu, Gautschi, Oliver, Coate, Linda, López Martín, Ana, van Heemst, Robbert, Berghmans, Thierry, Meldgaard, Peter, Cobo Dols, Manuel, Garde Noguera, Javier, Curioni-Fontecedro, Alessandra, Rauch, Daniel, Mark, Michael T., Cuffe, Sinead, Biesma, Bonne, van Henten, Arjen M.J., Juan Vidal, Óscar, Palmero Sanchez, Ramón, Villa Guzmán, José Carlos, Collado Martin, Ricardo, Peralta, Sergio, Insa, Amelia, Summers, Yvonne, Láng, István, Horgan, Anne, Ciardiello, Fortunato, de Hosson, Sander, Pieterman, Remge, Groen, Harry J.M., van den Berg, Paul M., Zielinski, Christoph C., Chittazhathu Kurian Kuruvilla, Yojena, Gasca-Ruchti, Adriana, Kassapian, Marie, Novello, Silvia, Torri, Valter, Tsourti, Zoi, Gregorc, Vanesa, Smit, Egbert F.
Publikováno v:
In Journal of Thoracic Oncology April 2017 12(4):752-762
Autor:
Stahel, Rolf A, Kassapian, Marie, Curioni-Fontecedro, Alessandra, Smit, Egbert F, Aix, Santiago Ponce, Massutí, Bartomeu, Meldgaard, Peter, Láng, István, Noguera, Javier Garde, Novello, Silvia, Horgan, Anne, Pieterman, Remge, Van Heemst, Robbert, Chittazhathu Kurian Kuruvilla, Yojena, Ciardiello, Fortunato, Van Henten, Arjen Mj, Coate, Linda, Vidal, Óscar Juan, Peters, Solange, Tsourti, Zoi, Groen, Harry Jm, Zielinski, Christoph C, Martin, Ricardo Collado, Rauch, Daniel, López Martín, Ana, Villa Guzmán, José Carlos, Gasca-Ruchti, Adriana, Peralta, Sergio, Biesma, Bonne, Torri, Valter, Sanchez, Ramón Palmero, Gautschi, Oliver, Berghmans, Thierry, Mark, Michael T, Cuffe, Sinead, Cobo Dols, Manuel, Gregorc, Vanesa, Van Den Berg, Paul M, Insa, Amelia, Summers, Yvonne, De Hosson, Sander, Dafni, Urania
INTRODUCTION Docetaxel and erlotinib are registered second-line treatments for wild-type EGFR NSCLC. Previous studies suggested a predictive value of the Veristrat test in second-line therapy of NSCLC, classifying patients as either Veristrat "good"
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55c2dc6ab2ff16a54077a7ca576371bb
Autor:
Milroy, Robert, Bajetta, Emilio, van den Berg, Paul M., ER OBrien, Mary, Perez-Manga, Gumersindo, Georgoulias, Vassilis, Greil, Richard, Ramlau, Rodryg
Publikováno v:
European Journal of Clinical & Medical Oncology; 2011, Vol. 3 Issue 2, p49-56, 8p, 1 Diagram, 3 Charts, 3 Graphs
Autor:
Hill, Norwood O., Manian, Farrin A., Mermel, Leonard A., Mann, Howard, Kiyosawa, Kendo, van den Berg, Paul M., Tanus, Tonny, Weiss, Kenneth S., Finucane, Thomas E.
Publikováno v:
Annals of Internal Medicine; 2/15/92, Vol. 116 Issue 4, p345, 5p
Publikováno v:
Interactive Cardiovascular and Thoracic Surgery; December 2003, Vol. 2 Issue: 4 p589-591, 3p